Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

A Cancer “Atlas” to Predict How Patients Will Fare

Researchers use a big-data approach to find links between different genes and patient survival.

Understanding the genetic changes in tumors that distinguish the most lethal cancers from more benign ones could help doctors better treat patients.

Today, Swedish researchers are launching a new open-access catalog that maps many of those genetic changes. This “atlas” links thousands of specific genes involved in numerous cancers to patient survival and also reveals potential new drug targets.

The new atlas is one of several ongoing efforts to make sense of data that’s been collected by public databases—like the National Cancer Institute’s Cancer Genome Atlas—that act as repositories for tumor samples. The goal is to glean practical information, like markers of disease, that can be used to develop cancer drugs and diagnostics.

To generate the atlas, researchers led by Mathias Uhlén, a professor of microbiology at the Royal Institute of Technology in Sweden, used a supercomputer to analyze 17 major types of human cancers from nearly 8,000 tumor samples. Uhlén says his team was looking for “holistic changes across the genome caused by these mutations.”

They then mapped all the genes found in those cancer cells to find out how proteins made by these genes affect patient survival. Genes carry instructions for making proteins, and the level of gene expression increases or decreases the amount of protein that genes make. These resulting proteins can dramatically influence biological processes like cancer.

Subscribe to The Download
What's important in technology and innovation, delivered to you every day.
Manage your newsletter preferences

The researchers observed that the levels of proteins in different cancers varied widely, reinforcing the need for personalized cancer treatment based on the unique characteristics of a patient’s tumor, they say.

The researchers found that more than 2,000 genes had varying effects on a patient’s survival depending upon cancer type and where the tumor was located in the body. In some cases, genes that were more highly expressed were associated with better patient outcomes, and others predicted worse outlooks for patients. The results are detailed today in the journal Science.

Uhlén and his team identified another set of more than 2,000 genes that could potentially kill tumor growth but says affecting most of those targets with drugs would likely have severe side effects for patients. Of those, they predict 32 genes found in more than 80 percent of tumors, regardless of the cancer type, represent drug targets.

Previously, researchers have focused on using DNA sequencing to identify genetic mutations involved in cancer. To make this new atlas, scientists used RNA sequencing to understand how genes change when affected by cancer.

John Leite, vice president of oncology at the gene sequencing company Illumina, says lots of biological information will be needed to understand the underlying mechanisms that drive cancer formation and ultimately allow researchers and physicians to predict the best therapy options for patients. That’s where this new atlas could help.

Nicolas Robine, assistant director of computational biology at the New York Genome Center, says the atlas will be a useful resource for researchers, but said it can’t provide a definitive, automated answer to physicians wondering how a patient’s cancer will progress. “It’s not like you plug in your expression profile and it tells you whether you have a better or worse outcome.”

The atlas is part of a Swedish program started in 2003 with the aim of mapping all of the human proteins made by the body’s some 20,000 or more genes.

Get stories like this before anyone else with First Look.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe and become an Insider.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look: exclusive early access to important stories, before they’re available to anyone else

    Insider Conversations: listen in on in-depth calls between our editors and today’s thought leaders

  • Insider Plus {! insider.prices.plus !}* Best Value

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus ad-free web experience, select discounts to partner offerings and MIT Technology Review events

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning magazine and daily delivery of The Download, our newsletter of what’s important in technology and innovation.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.